Histone H3 lysine 23 acetylation is associated with oncogene TRIM24 expression and a poor prognosis in breast cancer.

作者: Li Ma , Lili Yuan , Jing An , Michelle C. Barton , Qingyuan Zhang

DOI: 10.1007/S13277-016-5344-Z

关键词:

摘要: Acetylated H3 lysine 23 (H3K23ac) is a specific histone post-translational modification recognized by oncoprotein TRIM24. However, it not clear whether H3K23ac levels are correlated with TRIM24 expression and what role may have in cancer. In this study, we collected breast carcinoma samples from 121 patients conducted immunohistochemistry to determine the of Our results demonstrated that positively levels, high both predict shorter overall survival cancer patients. We also showed higher HER2-positive patients, their were HER2 Moreover, associated estrogen receptor (ER) progesterone (PR) statuses our cohort The Cancer Genome Atlas (TCGA) carcinoma. summary, revealed an important provided further evidence small-molecule inhibitors benefit ER- PR-negative or

参考文章(30)
James Bennett, Oleg Fedorov, Cynthia Tallant, Octovia Monteiro, Julia Meier, Vicky Gamble, Pavel Savitsky, Graciela A Nunez-Alonso, Bernard Haendler, Catherine Rogers, Paul E. Brennan, Susanne Müller, Stefan Knapp, Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF Journal of Medicinal Chemistry. ,vol. 59, pp. 1642- 1647 ,(2016) , 10.1021/ACS.JMEDCHEM.5B00458
J. Spona, A. Reiner, W. Kwasny, J. H. Holzner, G. Reiner, R. Függer, R. Kolb, M. Schemper, R. Jakesz, Estrogen receptor analysis on biopsies and fine-needle aspirates from human breast carcinoma. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. American Journal of Pathology. ,vol. 125, pp. 443- 449 ,(1986)
B. Le Douarin, A. L. Nielsen, J. M. Garnier, H. Ichinose, F. Jeanmougin, R. Losson, P. Chambon, A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. The EMBO Journal. ,vol. 15, pp. 6701- 6715 ,(1996) , 10.1002/J.1460-2075.1996.TB01060.X
Yen-Yi Juo, Xue-Jun Gong, Ankita Mishra, Xiao Cui, Stephen B Baylin, Nilofer S Azad, Nita Ahuja, Epigenetic therapy for solid tumors: from bench science to clinical trials Epigenomics. ,vol. 7, pp. 215- 235 ,(2015) , 10.2217/EPI.14.73
T N Pathiraja, K N Thakkar, S Jiang, S Stratton, Z Liu, M Gagea, X Shi, P K Shah, L Phan, M-H Lee, J Andersen, M Stampfer, M C Barton, TRIM24 links glucose metabolism with transformation of human mammary epithelial cells. Oncogene. ,vol. 34, pp. 2836- 2845 ,(2015) , 10.1038/ONC.2014.220
Monique Chambon, Béatrice Orsetti, Marie-Laurence Berthe, Caroline Bascoul-Mollevi, Carmen Rodriguez, Vanessa Duong, Michel Gleizes, Sandrine Thénot, Frédéric Bibeau, Charles Theillet, Vincent Cavaillès, Prognostic Significance of TRIM24/TIF-1α Gene Expression in Breast Cancer American Journal of Pathology. ,vol. 178, pp. 1461- 1469 ,(2011) , 10.1016/J.AJPATH.2010.12.026
Zhi-Feng Miao, Zhen-Ning Wang, Ting-Ting Zhao, Ying-Ying Xu, Jian-Hua Wu, Xing-Yu Liu, Hao Xu, Yi You, Hui-Mian Xu, TRIM24 is upregulated in human gastric cancer and promotes gastric cancer cell growth and chemoresistance. Virchows Archiv. ,vol. 466, pp. 525- 532 ,(2015) , 10.1007/S00428-015-1737-4
Konstantin Khetchoumian, Marius Teletin, Johan Tisserand, Manuel Mark, Benjamin Herquel, Mihaela Ignat, Jessica Zucman-Rossi, Florence Cammas, Thierry Lerouge, Christelle Thibault, Daniel Metzger, Pierre Chambon, Régine Losson, Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha. Nature Genetics. ,vol. 39, pp. 1500- 1506 ,(2007) , 10.1038/NG.2007.15
Maria-Christina Zennaro, Anny Souque, Say Viengchareun, Elodie Poisson, Marc Lombès, A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action. Molecular Endocrinology. ,vol. 15, pp. 1586- 1598 ,(2001) , 10.1210/MEND.15.9.0689